Whanin Pharm (016580)

Currency in KRW
10,630
+80(+0.76%)
Closed·
Earnings results expected in 14 days
016580 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
10,55010,730
52 wk Range
9,99013,210
Key Statistics
Bid/Ask
10,630.00 / 10,660.00
Prev. Close
10,550
Open
10,560
Day's Range
10,550-10,730
52 wk Range
9,990-13,210
Volume
22.05K
Average Volume (3m)
43.79K
1-Year Change
-9.5973%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
016580 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
14,000
Upside
+31.70%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low Price / Book multiple

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Buy

Whan In Pharm Co.,Ltd. manufactures and sells various pharmaceutical products in South Korea. The company offers products, such as gastrointestinal, respiratory, cardiovascular, antidiabetic, antibiotic, antifungal, antihistamine, antiviral, antirheumatic, muscle relaxant, nonsteroidal anti-inflammatory, smoking cessation, erectile dysfunction, prostate disease, urinary disorder, osteoporosis, antiseizure, antidepressant, antipsychotic, central nervous system stimulant, anti-dementia, nootropic, alcohol use disorder, anti-Parkinson, multivitamin, external preparation, medical device, and sedative, hypnotic, and autonomic nervous system medications. The company was founded in 1978 and is headquartered in Seoul, South Korea.

Employees
601

Compare 016580 to Peers and Sector

Metrics to compare
016580
Peers
Sector
Relationship
P/E Ratio
14.2x13.5x−0.4x
PEG Ratio
−0.33−0.190.00
Price/Book
0.5x0.9x2.6x
Price / LTM Sales
0.8x0.7x3.2x
Upside (Analyst Target)
32.7%34.2%46.7%
Fair Value Upside
Unlock11.6%7.6%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 14,000
(+31.70% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 857.41%
Dividend Yield
2.81%
Industry Median 0.93%
Annualized payout
300.00
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Mar 12, 2026
EPS / Forecast
119.91 / --
Revenue / Forecast
65.1B / 66.9B
EPS Revisions
Last 90 days

016580 Income Statement

People Also Watch

492,500
002960
-0.51%
1,463,000
012450
+2.67%
123,300
086790
+1.99%
9,830
084690
+1.13%
4,230
018880
0.00%

FAQ

What Is the Whanin Pharm (016580) Stock Price Today?

The Whanin Pharm stock price today is 10,630 KRW.

What Stock Exchange Does Whanin Pharm Trade On?

Whanin Pharm is listed and trades on the Seoul Stock Exchange.

What Is the Stock Symbol for Whanin Pharm?

The stock symbol for Whanin Pharm is "016580."

Does Whanin Pharm Pay Dividends? What’s The Current Dividend Yield?

The Whanin Pharm dividend yield is 2.81%.

What Is the Whanin Pharm Market Cap?

As of today, Whanin Pharm market cap is 195.01B KRW.

What Is Whanin Pharm's Earnings Per Share (TTM)?

The Whanin Pharm EPS (TTM) is 857.

When Is the Next Whanin Pharm Earnings Date?

Whanin Pharm will release its next earnings report on May 08, 2026.

From a Technical Analysis Perspective, Is 016580 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Whanin Pharm Stock Split?

Whanin Pharm has split 2 times.

How Many Employees Does Whanin Pharm Have?

Whanin Pharm has 601 employees.

What is the current trading status of Whanin Pharm (016580)?

As of Apr 24, 2026, Whanin Pharm (016580) is trading at a price of 10,630 KRW, with a previous close of 10,550 KRW. The stock has fluctuated within a day range of 10,550 KRW to 10,730 KRW, while its 52-week range spans from 9,990 KRW to 13,210 KRW.

What Is Whanin Pharm (016580) Price Target According to Analysts?

The average 12-month price target for Whanin Pharm is 14,000 KRW, with a high estimate of 14000 KRW and a low estimate of 14000 KRW. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +31.70% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.